Libertatis Ergo Holding B.V.
Overview
Libertatis Ergo Holding B.V. (LEH) is an independent investment firm wholly owned by Leiden University, dedicated to supporting and investing in startup and spinout companies associated with the university's activities. LEH primarily focuses on life science and health sectors, aiming to bridge the gap between academic research and market application by providing financial support and educational programs to facilitate the commercialization of innovative technologies. The firm's investment strategy emphasizes sustainable and ethical business practices, targeting companies that contribute positively to society and the environment. LEH operates as a lead seed investor, engaging in early-stage investments to foster the growth of high-impact technology ventures. Their portfolio includes a diverse range of sectors, such as biotechnology, medical devices, pharmaceuticals, and health technology, reflecting a commitment to advancing solutions that address significant societal challenges. LEH's approach combines deep academic insight with entrepreneurial expertise, leveraging its strong presence on the Leiden Bio Science Park to drive innovation. By supporting companies like River BioMedics, which secured €2 million in funding to advance its cardiovascular disease pipeline, and dHealthIQ, which received €500,000 to validate its AI platform for elderly care and rehabilitation, LEH demonstrates its dedication to fostering impactful ventures that align with its mission of promoting societal and environmental well-being.
Investment Focus
- Companies associated with Leiden University's activities
- Focus on life science and health sectors
- Commitment to sustainable and ethical business practices
- Early-stage ventures with high-impact technology solutions
Portfolio Companies
Reach Libertatis Ergo Holding B.V. directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Libertatis Ergo Holding B.V.
What sectors does Libertatis Ergo Holding B.V. invest in?
Libertatis Ergo Holding B.V. invests in Technology, Healthcare, HealthTech, Artificial Intelligence, Life Sciences and Digital Health, and is based in Leiden, Netherlands. Libertatis Ergo Holding B.V. is listed as a private investment firm in the ConnectSafely investor database.
What stage does Libertatis Ergo Holding B.V. invest at?
Libertatis Ergo Holding B.V. backs companies at Seed, Early Stage and Growth, writing cheques of 500K - 2M.
Which regions does Libertatis Ergo Holding B.V. invest in?
Libertatis Ergo Holding B.V. invests across Netherlands.
Who are the partners at Libertatis Ergo Holding B.V.?
Team members listed for Libertatis Ergo Holding B.V. include Rob Mayfield (Managing Director of Libertatis Ergo Holding B.V.) and Rob LEH (Managing Director).
What companies has Libertatis Ergo Holding B.V. invested in?
Libertatis Ergo Holding B.V.'s portfolio includes River BioMedics, dHealthIQ, OncoLize, Whispp, BIMINI Biotech and Cantoni Therapeutics.
How do I contact Libertatis Ergo Holding B.V.?
Libertatis Ergo Holding B.V.'s contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
